What difference does it make when patients often describe themselves as suffering from Parkinson’s syndrome and wanting to be treated by a pacemaker?
What are the causes and classifications of Parkinson’s syndrome?
The Parkinson syndrome refers in broad terms to the general name of the disease (Parkinsonism), in narrow sense to the non-PD disease (Parkinsonian), in parkinson, and, in general, to Parkinsonian, in clinical terms. These include the following types of disease:
The Puckinson Syndrome.
There is a risk of re-emergence in drug, vascular, mesotoxic, metabolic, neoplasm, post-encephalitis, brain trauma, etc.
Parkinson’s supermassive syndrome.
Multi-system atrophy, nucleotosis, Louis dementia, cortex base deformity, Huntington disease, hepato-beans nuclei.
Parkinson ‘ s disease is caused by the death of a neural dopamine of the inside of the skull, the cause of which is unknown and may be due to genetic factors, environmental factors, aging of the nervous system, pharmaceutical factors, infections, etc.
What difference does it make?
Parkinson ‘ s disease is mainly treated with drugs such as left-rotated doba, gold-goldaneamine, phenylhydrate, sledjilan and brain pacemaker. The Parkinson syndrome is based on active treatment of basic diseases, with some of the patients experiencing a natural reduction in symptoms following an improvement in the treatment of basic diseases, which can be supplemented by anti-Pakinsonian drugs.
Parkinson patients develop to the middle and late stages and have access to surgical treatment, but for Parkinson syndrome patients the treatment is less effective, which is why the brain pacemaker is the first to exclude the syndrome.
